Jami Mandelin

Kasvu Therapeutics Ltd is drug discovery and drug development company focusing in non-hallucinogenic enhancers of neuroplasticity with ambitious goal to treat depression, PTSD and different type of addictions. Kasvu has just been established with a support of knowledgeable investors, and it is in very early stage of discovery activities. The company relies in decades of science with highly validated drug target(s) in its development activities. We seek investors and partners who could be genuine partners in this long journey.